-
1
-
-
0035952364
-
Thyroid cancer
-
Gimm O. Thyroid cancer. Cancer Lett 2001;163:143-56.
-
(2001)
Cancer Lett
, vol.163
, pp. 143-156
-
-
Gimm, O.1
-
3
-
-
0142043830
-
Locally advanced differentiated thyroid cancer
-
DOI 10.1016/S0960-7404(03)00032-X
-
Kebebew E, Clark OH. Locally advanced differentiated thyroid cancer. Surg Oncol 2003;12:91-9. (Pubitemid 37289014)
-
(2003)
Surgical Oncology
, vol.12
, Issue.2
, pp. 91-99
-
-
Kebebew, E.1
Clark, O.H.2
-
5
-
-
2342559981
-
The TOR pathway: A target for cancer therapy
-
Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy. Nat Rev Cancer 2004;4:335-48.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 335-348
-
-
Bjornsti, M.A.1
Houghton, P.J.2
-
6
-
-
77950541904
-
Everolimus (RAD001) in the treatment of advanced renal cell carcinoma: A review
-
Agarwala SS, Case S. Everolimus (RAD001) in the treatment of advanced renal cell carcinoma: a review. Oncologist 2010;15:236-45.
-
(2010)
Oncologist
, vol.15
, pp. 236-245
-
-
Agarwala, S.S.1
Case, S.2
-
7
-
-
0030799090
-
Activating mutations for the met tyrosine kinase receptor in human cancer
-
Jeffers M, Schmidt L, Nakaigawa N, et al. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci U S A 1997;94:11445-50.
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, pp. 11445-11450
-
-
Jeffers, M.1
Schmidt, L.2
Nakaigawa, N.3
-
8
-
-
33750072949
-
mTOR and cancer therapy
-
Easton JB, Houghton PJ. mTOR and cancer therapy. Oncogene 2006;25:6436-46.
-
(2006)
Oncogene
, vol.25
, pp. 6436-6446
-
-
Easton, J.B.1
Houghton, P.J.2
-
9
-
-
34547683568
-
Rationale for a phase I trial of erlotinib and the mammalian target of rapamycin inhibitor everolimus (RAD001) for patients with relapsed non small cell lung cancer
-
Johnson BE, Jackman D, Janne PA. Rationale for a phase I trial of erlotinib and the mammalian target of rapamycin inhibitor everolimus (RAD001) for patients with relapsed non small cell lung cancer. Clin Cancer Res 2007;13:s4628-31.
-
(2007)
Clin Cancer Res
, vol.13
-
-
Johnson, B.E.1
Jackman, D.2
Janne, P.A.3
-
10
-
-
25444440875
-
The role of autophagy in cancer development and response to therapy
-
DOI 10.1038/nrc1692, PII N1692
-
Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005;5:726-34. (Pubitemid 41486365)
-
(2005)
Nature Reviews Cancer
, vol.5
, Issue.9
, pp. 726-734
-
-
Kondo, Y.1
Kanzawa, T.2
Sawaya, R.3
Kondo, S.4
-
11
-
-
1842583789
-
Development by self-digestion: Molecular mechanisms and biological functions of autophagy
-
Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004;6:463-77.
-
(2004)
Dev Cell
, vol.6
, pp. 463-477
-
-
Levine, B.1
Klionsky, D.J.2
-
12
-
-
11144245626
-
The role of autophagy during the early neonatal starvation period
-
Kuma A, Hatano M, Matsui M, et al. The role of autophagy during the early neonatal starvation period. Nature 2004;432:1032-6.
-
(2004)
Nature
, vol.432
, pp. 1032-1036
-
-
Kuma, A.1
Hatano, M.2
Matsui, M.3
-
13
-
-
12944303650
-
Growth factor regulation of autophagy and cell survival in the absence of apoptosis
-
DOI 10.1016/j.cell.2004.11.046, PII S009286740401150X
-
Lum JJ, Bauer DE, Kong M, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005;120:237-48. (Pubitemid 40174766)
-
(2005)
Cell
, vol.120
, Issue.2
, pp. 237-248
-
-
Lum, J.J.1
Bauer, D.E.2
Kong, M.3
Harris, M.H.4
Li, C.5
Lindsten, T.6
Thompson, C.B.7
-
14
-
-
25144457455
-
Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy
-
Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005;122:927-39.
-
(2005)
Cell
, vol.122
, pp. 927-939
-
-
Pattingre, S.1
Tassa, A.2
Qu, X.3
-
15
-
-
0025283961
-
Developmental cell death: Morphological diversity and multiple mechanisms
-
Berl
-
Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 1990;181:195-213.
-
(1990)
Anat Embryol
, vol.181
, pp. 195-213
-
-
Clarke, P.G.1
-
16
-
-
0142219885
-
Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10
-
Stassi G, Todaro M, Zerilli M, et al. Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10. Cancer Res 2003;63:6784-90.
-
(2003)
Cancer Res
, vol.63
, pp. 6784-6790
-
-
Stassi, G.1
Todaro, M.2
Zerilli, M.3
-
17
-
-
70549107878
-
Autophagy: A new target for advanced papillary thyroid cancer therapy
-
Lin CI, Whang EE, Abramson MA, et al. Autophagy: a new target for advanced papillary thyroid cancer therapy. Surgery 2009;146:1208-14.
-
(2009)
Surgery
, vol.146
, pp. 1208-1214
-
-
Lin, C.I.1
Whang, E.E.2
Abramson, M.A.3
-
18
-
-
18144399578
-
MTOR-targeted therapy of cancer with rapamycin derivatives
-
DOI 10.1093/annonc/mdi113
-
Vignot S, Faivre S, Aguirre D, Raymond E. mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol 2005;16:525-37. (Pubitemid 40613318)
-
(2005)
Annals of Oncology
, vol.16
, Issue.4
, pp. 525-537
-
-
Vignot, S.1
Faivre, S.2
Aguirre, D.3
Raymond, E.4
-
19
-
-
34248575532
-
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts
-
Puri N, Khramtsov A, Ahmed S, et al. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts. Cancer Res 2007;67:3529-34.
-
(2007)
Cancer Res
, vol.67
, pp. 3529-3534
-
-
Puri, N.1
Khramtsov, A.2
Ahmed, S.3
-
20
-
-
19944428353
-
Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin- 4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays
-
Lombardo LJ, Lee FY, Chen P, et al. Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin- 4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem 2004;47:6658-61.
-
(2004)
J Med Chem
, vol.47
, pp. 6658-6661
-
-
Lombardo, L.J.1
Lee, F.Y.2
Chen, P.3
-
21
-
-
58149525787
-
Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells
-
Lin CI, Whang EE, Abramson MA, et al. Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells. Biochem Biophys Res Commun 2009;379:626-31.
-
(2009)
Biochem Biophys Res Commun
, vol.379
, pp. 626-631
-
-
Lin, C.I.1
Whang, E.E.2
Abramson, M.A.3
-
22
-
-
72449155680
-
Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer
-
Lin CI, Whang EE, Donner DB, et al. Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer. Mol Cancer Res 2009;7:1655-62.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 1655-1662
-
-
Lin, C.I.1
Whang, E.E.2
Donner, D.B.3
-
23
-
-
0037020196
-
The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini
-
Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 2002;111:29-40.
-
(2002)
Cell
, vol.111
, pp. 29-40
-
-
Debnath, J.1
Mills, K.R.2
Collins, N.L.3
Reginato, M.J.4
Muthuswamy, S.K.5
Brugge, J.S.6
-
24
-
-
2642553881
-
Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8
-
Yu L, Alva A, Su H, et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004;304:1500-2.
-
(2004)
Science
, vol.304
, pp. 1500-1502
-
-
Yu, L.1
Alva, A.2
Su, H.3
-
25
-
-
33745728135
-
Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor
-
Carothers AM, Moran AE, Cho NL, Redston M, Bertagnolli MM. Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor. Cancer Res 2006;66:6432-8.
-
(2006)
Cancer Res
, vol.66
, pp. 6432-6438
-
-
Carothers, A.M.1
Moran, A.E.2
Cho, N.L.3
Redston, M.4
Bertagnolli, M.M.5
-
26
-
-
59249105964
-
Monitoring autophagic degradation of p62/SQSTM1
-
Bjorkoy G, Lamark T, Pankiv S, Overvatn A, Brech A, Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol 2009;452:181-97.
-
(2009)
Methods Enzymol
, vol.452
, pp. 181-197
-
-
Bjorkoy, G.1
Lamark, T.2
Pankiv, S.3
Overvatn, A.4
Brech, A.5
Johansen, T.6
-
27
-
-
0021970996
-
Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models
-
Mirabelli CK, Johnson RK, Sung CM, Faucette L, Muirhead K, Crooke ST. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models. Cancer Res 1985;45:32-9.
-
(1985)
Cancer Res
, vol.45
, pp. 32-39
-
-
Mirabelli, C.K.1
Johnson, R.K.2
Sung, C.M.3
Faucette, L.4
Muirhead, K.5
Crooke, S.T.6
-
28
-
-
60149089005
-
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
-
Du J, Bernasconi P, Clauser KR, et al. Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy. Nat Biotechnol 2009;27:77-83.
-
(2009)
Nat Biotechnol
, vol.27
, pp. 77-83
-
-
Du, J.1
Bernasconi, P.2
Clauser, K.R.3
-
29
-
-
20144381544
-
Essential roles of Atg5 and FADD in autophagic cell death: Dissection of autophagic cell death into vacuole formation and cell death
-
Pyo JO, Jang MH, Kwon YK, et al. Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem 2005;280:20722-9.
-
(2005)
J Biol Chem
, vol.280
, pp. 20722-20729
-
-
Pyo, J.O.1
Jang, M.H.2
Kwon, Y.K.3
-
30
-
-
33745864334
-
Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum
-
Buytaert E, Callewaert G, Vandenheede JR, Agostinis P. Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum. Autophagy 2006;2:238-40. (Pubitemid 44030895)
-
(2006)
Autophagy
, vol.2
, Issue.3
, pp. 238-240
-
-
Buytaert, E.1
Callewaert, G.2
Vandenheede, J.R.3
Agostinis, P.4
-
31
-
-
23044439544
-
RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer
-
Homicsko K, Lukashev A, Iggo RD. RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer. Cancer Res 2005;65:6882-90.
-
(2005)
Cancer Res
, vol.65
, pp. 6882-6890
-
-
Homicsko, K.1
Lukashev, A.2
Iggo, R.D.3
-
32
-
-
34547130295
-
RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model
-
Mabuchi S, Altomare DA, Cheung M, et al. RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model. Clin Cancer Res 2007;13:4261-70.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 4261-4270
-
-
Mabuchi, S.1
Altomare, D.A.2
Cheung, M.3
-
33
-
-
70350378811
-
Role of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer
-
Papewalis C, Wuttke M, Schinner S, et al. Role of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer. Horm Metab Res 2009;41:752-6.
-
(2009)
Horm Metab Res
, vol.41
, pp. 752-756
-
-
Papewalis, C.1
Wuttke, M.2
Schinner, S.3
-
35
-
-
34047253075
-
RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer
-
Mabuchi S, Altomare DA, Connolly DC, et al. RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer. Cancer Res 2007;67:2408-13.
-
(2007)
Cancer Res
, vol.67
, pp. 2408-2413
-
-
Mabuchi, S.1
Altomare, D.A.2
Connolly, D.C.3
-
36
-
-
57349106607
-
Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma
-
Tam KH, Yang ZF, Lau CK, Lam CT, Pang RW, Poon RT. Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma. Cancer Lett 2009;273:201-9.
-
(2009)
Cancer Lett
, vol.273
, pp. 201-209
-
-
Tam, K.H.1
Yang, Z.F.2
Lau, C.K.3
Lam, C.T.4
Pang, R.W.5
Poon, R.T.6
-
37
-
-
58249085318
-
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer
-
Wolpin BM, Hezel AF, Abrams T, et al. Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer. J Clin Oncol 2009;27:193-8.
-
(2009)
J Clin Oncol
, vol.27
, pp. 193-198
-
-
Wolpin, B.M.1
Hezel, A.F.2
Abrams, T.3
-
38
-
-
60849137218
-
Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma
-
Milano V, Piao Y, LaFortune T, de Groot J. Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma. Mol Cancer Ther 2009;8:394-406.
-
(2009)
Mol Cancer Ther
, vol.8
, pp. 394-406
-
-
Milano, V.1
Piao, Y.2
LaFortune, T.3
De Groot, J.4
-
39
-
-
67349286024
-
Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line
-
Mazzanti R, Platini F, Bottini C, Fantappie O, Solazzo M, Tessitore L. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line. Biochem Pharmacol 2009;78:21-32.
-
(2009)
Biochem Pharmacol
, vol.78
, pp. 21-32
-
-
Mazzanti, R.1
Platini, F.2
Bottini, C.3
Fantappie, O.4
Solazzo, M.5
Tessitore, L.6
-
40
-
-
21444442926
-
Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells
-
Ito H, Daido S, Kanzawa T, Kondo S, Kondo Y. Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. Int J Oncol 2005;26:1401-10.
-
(2005)
Int J Oncol
, vol.26
, pp. 1401-1410
-
-
Ito, H.1
Daido, S.2
Kanzawa, T.3
Kondo, S.4
Kondo, Y.5
-
41
-
-
33845974091
-
Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling
-
Kim KW, Mutter RW, Cao C, et al. Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling. J Biol Chem 2006;281:36883-90.
-
(2006)
J Biol Chem
, vol.281
, pp. 36883-36890
-
-
Kim, K.W.1
Mutter, R.W.2
Cao, C.3
-
42
-
-
48249090416
-
Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer
-
Kim KW, Hwang M, Moretti L, Jaboin JJ, Cha YI, Lu B. Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 2008;4:659-68.
-
(2008)
Autophagy
, vol.4
, pp. 659-668
-
-
Kim, K.W.1
Hwang, M.2
Moretti, L.3
Jaboin, J.J.4
Cha, Y.I.5
Lu, B.6
-
43
-
-
0037306785
-
Molecular response of human glioblastoma multiforme cells to ionizing radiation: Cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy
-
Yao KC, Komata T, Kondo Y, Kanzawa T, Kondo S, Germano IM. Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy. J Neurosurg 2003;98:378-84.
-
(2003)
J Neurosurg
, vol.98
, pp. 378-384
-
-
Yao, K.C.1
Komata, T.2
Kondo, Y.3
Kanzawa, T.4
Kondo, S.5
Germano, I.M.6
-
44
-
-
33750565745
-
Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells
-
Cao C, Subhawong T, Albert JM, et al. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res 2006;66:10040-7.
-
(2006)
Cancer Res
, vol.66
, pp. 10040-10047
-
-
Cao, C.1
Subhawong, T.2
Albert, J.M.3
-
45
-
-
10344262564
-
Role of Bcl-2 family proteins in a non-apoptopic programmed cell death dependent on autophagy genes
-
DOI 10.1038/ncb1192
-
Shimizu S, Kanaseki T, Mizushima N, et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004;6:1221-8. (Pubitemid 39625121)
-
(2004)
Nature Cell Biology
, vol.6
, Issue.12
, pp. 1221-1228
-
-
Shimizu, S.1
Kanaseki, T.2
Mizushima, N.3
Mizuta, T.4
Arakawa-Kobayashi, S.5
Thompson, C.B.6
Tsujimoto, Y.7
-
46
-
-
25144506835
-
Autophagy in cell death: An innocent convict?
-
Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest 2005;115:2679-88.
-
(2005)
J Clin Invest
, vol.115
, pp. 2679-2688
-
-
Levine, B.1
Yuan, J.2
|